OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?

OptimizeRx OPRX delivered solid first-quarter 2025 results, with revenues rising 11% year over year to $21.9 million and adjusted EBITDA improving to $1.5 million. But beyond these financials, the company’s momentum increasingly hinges on the performance and adoption of its proprietary digital health tools — particularly its DAAP (Dynamic Audience...